By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ohr Pharmaceutical 

1245 Brickyard Road
Suite 590
Salt Lake City  Utah  84106  U.S.A.
Phone: 347-753-4389 Fax: n/a



Company News
Ohr Pharmaceutical (OHRP) Added To The Russell Indexes 6/30/2014 7:39:25 AM
Vista Partners Updates Coverage On Ohr Pharmaceutical (OHRP) (NASDAQ: OHRP); Raises Price Target To $31 6/27/2014 10:46:24 AM
Ohr Pharmaceutical (OHRP) To Host Conference Call And Webcast To Discuss Squalamine Interim Phase 2 Data In Wet-AMD 6/24/2014 7:43:48 AM
Ohr Pharmaceutical (OHRP) Eye Drug Falls Short In Phase 2 Trial 6/24/2014 7:00:52 AM
Ohr Pharmaceutical (OHRP) Announces Closing Of SKS Ocular Acquisition; Strengthens Executive Management Team 6/2/2014 9:26:08 AM
Ohr Pharmaceutical (OHRP) Announces Agreement To Acquire Technology Assets Of SKS Ocular 5/16/2014 11:59:21 AM
Ohr Pharmaceutical (OHRP) Announces Initiation Of Investigator Sponsored Trial Of Squalamine Eye Drops In Diabetic Macular Edema 5/9/2014 9:47:56 AM
Ohr Pharmaceutical (OHRP) Announces Completion Of Enrollment In Phase 2 Clinical Trial Of Squalamine Eye Drops In Wet-AMD 4/29/2014 9:40:06 AM
Ohr Pharmaceutical (OHRP) Announces $18 Million Registered Direct Offering Of Common Stock 4/8/2014 7:27:26 AM
Ohr Pharmaceutical (OHRP) To Present At The 26th Annual ROTH Conference 3/10/2014 9:48:28 AM